114 related articles for article (PubMed ID: 8389736)
41. [HLA typing in high risk keratoplasty].
Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
[TBL] [Abstract][Full Text] [Related]
42. Seeking beyond rejection: an update on the differential diagnosis and a practical approach to liver allograft biopsy interpretation.
Gao ZH
Adv Anat Pathol; 2009 Mar; 16(2):97-117. PubMed ID: 19550371
[TBL] [Abstract][Full Text] [Related]
43. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients.
Herzog D; Soglio DB; Fournet JC; Martin S; Marleau D; Alvarez F
Liver Transpl; 2008 Jul; 14(7):946-55. PubMed ID: 18581476
[TBL] [Abstract][Full Text] [Related]
44. Post-transplantation antibody monitoring and HLA antibody epitope identification.
Cai J; Terasaki PI
Curr Opin Immunol; 2008 Oct; 20(5):602-6. PubMed ID: 18692134
[TBL] [Abstract][Full Text] [Related]
45. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
[TBL] [Abstract][Full Text] [Related]
46. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation.
Matinlauri IH; Höckerstedt KA; Isoniemi HM
Clin Transplant; 2005 Oct; 19(5):626-31. PubMed ID: 16146554
[TBL] [Abstract][Full Text] [Related]
47. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
[TBL] [Abstract][Full Text] [Related]
48. Problems in the interpretation of liver biopsies after liver transplantation.
Snover DC
Am J Surg Pathol; 1989; 13 Suppl 1():31-8. PubMed ID: 2699166
[TBL] [Abstract][Full Text] [Related]
49. Immunopathology of liver transplantation.
Demetris AJ; Markus BH
Crit Rev Immunol; 1989; 9(2):67-92. PubMed ID: 2663025
[TBL] [Abstract][Full Text] [Related]
50. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts.
Evans PC; Coleman N; Wreghitt TG; Wight DG; Alexander GJ
J Hepatol; 1999 Nov; 31(5):913-20. PubMed ID: 10580590
[TBL] [Abstract][Full Text] [Related]
51. Different features of acute liver allograft rejection, their outcome and possible relationship to HLA-compatibility.
Gubernatis G; Kemnitz J; Tusch G; Ringe B; Bunzendahl H; Riedel T; Müller R; Pichlmayr R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2213-4. PubMed ID: 2652714
[No Abstract] [Full Text] [Related]
52. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
[TBL] [Abstract][Full Text] [Related]
53. Modified patterns of major histocompatibility complex-antigen expression in human liver grafts during rejection.
Steinhoff G; Wonigeit K; Ringe B; Lauchart W; Kemnitz J; Pichlmayr R
Transplant Proc; 1987 Feb; 19(1 Pt 3):2466-9. PubMed ID: 3547933
[No Abstract] [Full Text] [Related]
54. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure.
Wiesner RH; Ludwig J; van Hoek B; Krom RA
Hepatology; 1991 Oct; 14(4 Pt 1):721-9. PubMed ID: 1916676
[TBL] [Abstract][Full Text] [Related]
55. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection.
Ludwig J; Hashimoto E; Porayko MK; Therneau TM
Liver Transpl Surg; 1996 May; 2(3):185-91. PubMed ID: 9346647
[TBL] [Abstract][Full Text] [Related]
56. Antibody deposition in liver allografts with chronic rejection.
Demetris AJ; Markus BH; Burnham J; Nalesnik M; Gordon RD; Makowka L; Starzl TE
Transplant Proc; 1987 Aug; 19(4 Suppl 5):121-5. PubMed ID: 3303563
[No Abstract] [Full Text] [Related]
57. The immunological role of biliary epithelial cells in human liver transplant rejection.
Scholz M; Auth MK; Markus BH
Transpl Immunol; 1997 Jun; 5(2):142-51. PubMed ID: 9269037
[TBL] [Abstract][Full Text] [Related]
58. [Liver transplantation and the major histocompatibility complex].
Bismuth A; Ducot B; Samuel D; Arulnaden JL; Gugenheim J; Debat P; Azoulay D; Farrokhi P; Pillier-Loriette C; Bourdon G
Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):449-57. PubMed ID: 1772528
[TBL] [Abstract][Full Text] [Related]
59. Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss.
Quaglia AF; Del Vecchio Blanco G; Greaves R; Burroughs AK; Dhillon AP
J Hepatol; 2000 Nov; 33(5):773-80. PubMed ID: 11097486
[TBL] [Abstract][Full Text] [Related]
60. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation.
Paya CV; Wiesner RH; Hermans PE; Larson-Keller JJ; Ilstrup DM; Krom RA; Moore SB; Ludwig J; Smith TF
Hepatology; 1992 Jul; 16(1):66-70. PubMed ID: 1319956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
